Company / Operating Cash Flow
Organogenesis Holdings Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$30.9M
FY2025
5-year range
-$33.5M / $62.0M
FY2021-FY2025
Trend
+24.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$61M in FY2020 to $62M in FY2023.
Based on SEC 10-K filings.
$31M in FY2025 with a 3-year CAGR of +78.2%.
Declined from $62M to $31M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +78.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +78.2%, indicating consistent growth.
- In FY2025, operating cash flow increased 24.4% year-over-year.
- Peak operating cash flow was recorded in FY2023.
- Lowest operating cash flow in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.9M | +24.4% |
| FY2024 | $24.9M | -59.9% |
| FY2023 | $62.0M | +1033.9% |
| FY2022 | $5.5M | +116.3% |
| FY2021 | -$33.5M | +44.7% |
| FY2020 | -$60.6M | -1635.9% |
| FY2019 | -$3.5M | +28.3% |
| FY2018 | -$4.9M | -766.4% |
| FY2017 | -$562.2K | +0.0% |
| FY2016 | -$562.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026